Short- and long-term effects of amoxicillin/clavulanic acid or doxycycline on the gastrointestinal microbiome of growing cats

dc.contributor.authorStavroulaki, Evangelia M.
dc.contributor.authorSuchodolski, Jan S.
dc.contributor.authorPilla, Rachel
dc.contributor.authorFosgate, Geoffrey Theodore
dc.contributor.authorSung, Chi-Hsuan
dc.contributor.authorLidbury, Jonathan
dc.contributor.authorSteiner, Jorg M.
dc.contributor.authorXenoulis, Panagiotis G.
dc.date.accessioned2022-10-06T09:36:24Z
dc.date.available2022-10-06T09:36:24Z
dc.date.issued2021-12-15
dc.descriptionS1 Fig. Beta diversity indices among groups. A) Principal Coordinate Analysis of unweighted UniFrac distances of 16S rRNA genes representing the difference in microbial communities among cats treated with amoxicillin clavulanic acid (blue circles), cats treated with doxycycline (yellow circles), and healthy control cats (red circles) on days 20/28 (last day of treatment), 60, 120, and 300. B) Principal Coordinate Analysis of weighted UniFrac distances of 16S rRNA genes representing the difference in microbial communities among cats treated with amoxicillin clavulanic acid (blue circles), cats treated with doxycycline (yellow circles), and healthy control cats (red circles) on days 20/28 (last day of treatment), 60, 120, and 300.en_US
dc.descriptionS2 Fig. Rarefaction curves for A) Chao1, B) Observed ASVs, and C) Shannon Index.en_US
dc.descriptionS1 Table. Clinical data of cats participating to the study.en_US
dc.descriptionS2 Table. Alpha diversity metrics (mean ± standard deviation) with summary statistics; CON, healthy cats that did not receive antibiotics; AMC, cats treated with amoxicillin/clavulanic acid for 20 days; DOX, cats treated with doxycycline for 28 days.en_US
dc.descriptionS3 Table. Beta diversity differences based on ANOSIM analysis. CON, healthy cats that did not receive antibiotics; AMC, cats treated with amoxicillin/clavulanic acid for 20 days; DOX, cats treated with doxycycline for 28 days.en_US
dc.descriptionS4 Table. Beta diversity differences based on PERMANOVA analysis. CON, healthy cats that did not receive antibiotics; AMC, cats treated with amoxicillin/clavulanic acid for 20 days; DOX, cats treated with doxycycline for 28 days.en_US
dc.descriptionS5 Table. Summary statistics of sequencing data describing the mean percent and standard deviation of sequences belonging to antibiotic-treated (AMC and DOX groups) and healthy (CON group) cats.en_US
dc.descriptionS6 Table. Summary statistics of qPCR data describing the mean log abundance and standard deviation of bacterial groups belonging to antibiotic-treated (AMC and DOX groups) and healthy (CON group) cats.en_US
dc.description.abstractAntibiotic treatment in early life influences gastrointestinal (GI) microbial composition and function. In humans, the resultant intestinal dysbiosis is associated with an increased risk for certain diseases later in life. The objective of this study was to determine the temporal effects of antibiotic treatment on the GI microbiome of young cats. Fecal samples were collected from cats randomly allocated to receive either amoxicillin/clavulanic acid (20 mg/kg q12h) for 20 days (AMC group; 15 cats) or doxycycline (10 mg/kg q24h) for 28 days (DOX group;15 cats) as part of the standard treatment of upper respiratory tract infection. In addition, feces were collected from healthy control cats (CON group;15 cats). All cats were approximately two months of age at enrolment. Samples were collected on days 0 (baseline), 20 or 28 (AMC and DOX, respectively; last day of treatment), 60, 120, and 300. DNA was extracted and sequencing of the 16S rRNA gene and qPCR assays were performed. Fecal microbial composition was different on the last day of treatment for AMC cats, and 1 month after the end of antibiotic treatment for DOX cats, compared to CON cats. Species richness was significantly greater in DOX cats compared to CON cats on the last day of treatment. Abundance of Enterobacteriales was increased, and that of Erysipelotrichi was decreased in cats of the AMC group on the last day of treatment compared to CON cats. The abundance of the phylum Proteobacteria was increased in cats of the DOX group on days 60 and 120 compared to cats of the CON group. Only minor differences in abundances between the treatment groups and the control group were present on day 300. Both antibiotics appear to delay the developmental progression of the microbiome, and this effect is more profound during treatment with amoxicillin/clavulanic acid and one month after treatment with doxycycline. Future studies are required to determine if these changes influence microbiome function and whether they have possible effects on disease susceptibility in cats.en_US
dc.description.departmentProduction Animal Studiesen_US
dc.description.librarianam2022en_US
dc.description.sponsorshipThe Miller Trust Award of the Winn Feline Foundation.en_US
dc.description.urihttp://www.plosone.orgen_US
dc.identifier.citationStavroulaki, E.M., Suchodolski, J.S., Pilla, R., Fosgate, G.T., Sung, C.-H., Lidbury, J.A. et al. (2021) Short- and long-term effects of amoxicillin/clavulanic acid or doxycycline on the gastrointestinal microbiome of growing cats. PLoS ONE 16(12): e0253031. https://DOI.org/10.1371/journal.pone.0253031.en_US
dc.identifier.issn1932-6203 (online)
dc.identifier.other10.1371/journal.pone.0253031
dc.identifier.urihttps://repository.up.ac.za/handle/2263/87561
dc.language.isoenen_US
dc.publisherPublic Library of Scienceen_US
dc.rights© 2021 Stavroulaki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.en_US
dc.subjectCatsen_US
dc.subjectTreatmenten_US
dc.subjectDoxycyclineen_US
dc.subjectTemporal effectsen_US
dc.subjectAntibiotic treatmenten_US
dc.subjectGastrointestinal microbiomeen_US
dc.titleShort- and long-term effects of amoxicillin/clavulanic acid or doxycycline on the gastrointestinal microbiome of growing catsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 5 of 9
Loading...
Thumbnail Image
Name:
Stavroulaki_ShortAndLongTerm_2021.pdf
Size:
2.88 MB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Stavroulaki_ShortAndLongTermFigS1_2021.docx
Size:
313.12 KB
Format:
Microsoft Word XML
Description:
Figure S1
Loading...
Thumbnail Image
Name:
Stavroulaki_ShortAndLongTermFigS2_2021.docx
Size:
344.03 KB
Format:
Microsoft Word XML
Description:
Figure S2
Loading...
Thumbnail Image
Name:
Stavroulaki_ShortAndLongTermTabS1_2021.xlsx
Size:
13.88 KB
Format:
Microsoft Excel XML
Description:
Table S1
Loading...
Thumbnail Image
Name:
Stavroulaki_ShortAndLongTermTabS2_2021.xlsx
Size:
15.21 KB
Format:
Microsoft Excel XML
Description:
Table S2

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: